Compare State Street PDR S&P Retail ETF (XRT) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
State Street PDR S&P Retail ETF vs Zimmer Biomet Holdings Inc — how do they compare? State Street PDR S&P Retail ETF trades at $84.3, while Zimmer Biomet Holdings Inc trades at $94.73 (market cap $17.97B). The key difference: Zimmer Biomet Holdings Inc pays a 1.02% dividend while State Street PDR S&P Retail ETF pays none, and Zimmer Biomet Holdings Inc is trading nearer its 52-week high, State Street PDR S&P Retail ETF nearer its low. Which is the better fit depends on your goals.
| XRT | ZBH | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $92.35 | $104.26 |
52-Week Low | $77.28 | $79.58 |
Market Cap | — | $17.97B |
Enterprise Value | — | $25.04B |
Dividend Yield | — | 1.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
XRT (SPDR S&P Retail ETF) trades at $85.70, down 2.16% amid bearish technical signals, with moving averages indicating a downtrend and RSI levels in neutral territory. Recent news highlights unusual options activity with a 145% surge in put volume (Defense World, 2026-09-09) and mixed retail sector data, including a 0.6% drop in July sales (ETF Trends, 2026-08-14). The ETF offers exposure to consumer discretionary retail, with a dividend scheduled for June 2026.
Outlook is cautious due to technical weakness and sector headwinds like inflation and shifting consumer spending. Risks include economic sensitivity and competitive pressures, but potential exists if retail resilience improves. Investors should weigh bearish signals against long-term value opportunities in selective retail segments.
Zimmer Biomet (ZBH) trades at $94.22, down 3.93% on the day, with a bearish technical signal but strong fundamentals including a 69.87% gross margin and three consecutive quarterly earnings beats. Revenue growth is steady, reaching $8.23B in 2025, though net income margin dipped to 8.56%. Recent leadership promotions aim to accelerate commercial transformation, while analyst consensus price target is $104.88, implying 11.3% upside.
The stock presents a value opportunity with a P/E of 22.87 and P/S of 2.17, supported by robust cash flow and dividend payments. Risks include rising debt-to-asset ratio (32.57% in 2025) and competitive pressures. Wall Street sentiment is mixed with 40.48% buy ratings, but technical indicators suggest near-term caution amid bearish moving averages.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About State Street PDR S&P Retail ETF
XRT is an equal-weighted ETF that tracks the U.S. retail sector. It provides diversified exposure to apparel, automotive, and online retailers, including well-known names like Amazon, Target, and Costco.
Read more on XRT →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
